PRKAA1 and neoplasm: While numerous findings have reported that the overexpression of AMPK inhibits tumor growth and metastasis, a growing body of evidence has indeed proposed that activation of AMPK in cancer cells might support their survival, particularly at the initial stages of tumor development [29,41,42,43].